- 全部删除
- 您的购物车当前为空
HRS-4642 为针对 KRAS(G12D) 的选择性抑制剂,解离常数 (Kd) 为 0.083 nM,显示出抗癌活性。此化合物与 Carfilzomib 协同作用,显著提升体内效力,并能转变肿瘤微环境为免疫激活状态。
为众多的药物研发团队赋能,
让新药发现更简单!
HRS-4642 为针对 KRAS(G12D) 的选择性抑制剂,解离常数 (Kd) 为 0.083 nM,显示出抗癌活性。此化合物与 Carfilzomib 协同作用,显著提升体内效力,并能转变肿瘤微环境为免疫激活状态。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 5,660 | In stock | |
5 mg | ¥ 11,600 | In stock | |
10 mg | ¥ 15,900 | In stock | |
25 mg | ¥ 23,600 | In stock | |
50 mg | ¥ 31,900 | In stock | |
1 mL x 10 mM (in DMSO) | ¥ 14,500 | In stock |
HRS-4642 相关产品
产品描述 | HRS-4642 is a selective KRAS(G12D) inhibitor (Kd=0.083 nM) with anticancer activity. It demonstrates significant in vivo efficacy in combination with Carfilzomib, synergistically remodeling the tumor microenvironment into an immune-activating one. |
靶点活性 | KRas (G12D):0.083 nM (Ki) |
分子量 | 632.68 |
分子式 | C34H35F3N6O3 |
CAS No. | 2836263-09-1 |
颜色 | White |
物理性状 | Solid |
存储 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容